Coating of Flat Substrates, Medicine-Technical Application, Fraunhofer Institute for Electron Beam and Plasma Technology FEP, Winterbergstrasse 28, 01277, Dresden, Germany,
Graefes Arch Clin Exp Ophthalmol. 2014 Jan;252(1):77-82. doi: 10.1007/s00417-013-2482-5. Epub 2013 Oct 22.
To keep the loss of endothelial cell density in donor corneas to a minimum, a storage medium which is adjusted to their nutritional needs is necessary. Different media, used either serum-supplemented or serum-free, are available. The quality of medium- and serum-batches as well as support of endothelial cell viability by the medium are to be tested with a quality assured screening system that allows routine examination.
A screening system was developed which is based on cell-culture tests with the well-established human corneal endothelial cell line HCEC-12, and therefore can be performed without the need for donor corneas. The cells are plated at a defined density in cell-culture dishes, and are cultured for a defined period of time in the test media. Evaluation is carried out by assaying cell count, activity of cell metabolism (resazurin conversion), and determining the number of apoptotic and necrotic cells (combined vital staining with YO-PRO®-1/propidium iodide and subsequent flow cytometry).
Human corneal endothelial cells that are cultured in a medium which is adjusted to their nutritional needs achieve higher cell numbers and show a higher metabolic rate. Simultaneously, the percentage of apoptotic and necrotic cells is lower. The screening system developed in this study allows for easy and reliable detection of slightest differences between different media, different processing steps for same media, and different supplements, as well as different serum batches.
The differentiated results show that the screening system is sensitive enough to show even minor quality differences. Therefore, it is more suitable than the hitherto commonly used growth assay with primary, mostly porcine, corneal endothelial cells.
为了将供体角膜内皮细胞密度的损失降至最低,需要一种能够根据其营养需求进行调整的储存介质。有不同的培养基可供选择,包括添加血清或不添加血清的培养基。需要使用质量保证的筛选系统来测试培养基的批次质量和对内皮细胞活力的支持能力,该系统允许进行常规检查。
我们开发了一种筛选系统,该系统基于与人眼角膜内皮细胞系 HCEC-12 进行的细胞培养测试,因此无需使用供体角膜即可进行。将细胞以特定密度接种在细胞培养皿中,并在测试培养基中培养规定的时间。通过检测细胞计数、细胞代谢活性(resazurin 转化)以及确定凋亡和坏死细胞的数量(YO-PRO®-1/碘化丙啶联合活细胞染色和随后的流式细胞术)来进行评估。
在营养需求得到满足的培养基中培养的人眼角膜内皮细胞可达到更高的细胞数量,并表现出更高的代谢率。同时,凋亡和坏死细胞的比例较低。本研究中开发的筛选系统可轻松可靠地检测不同培养基之间、同一培养基的不同处理步骤之间以及不同补充剂和不同血清批次之间的最细微差异。
分化结果表明,该筛选系统足够敏感,即使是微小的质量差异也能显示出来。因此,它比迄今为止常用的基于原代(主要是猪)角膜内皮细胞的生长测定法更适合。